Skip to Main Content
Appendix 1




  • ACT: Activated clotting time Table 1A and B:

  • ACS: Acute coronary syndrome

  • Afib: Atrial fibrillation

  • Anesth.: Anesthesia

  • aPTT: Activated partial thromboplastin time

  • ASA: Acetylsalicylic acid

  • ATE: Arterial thromboembolism

  • BMS: Bare metal stent

  • COX: cyclooxygenase

  • CrCl: Creatinine clearance

  • CV: CHA2DS2-VASc

  • CVA: Cerebral vascular accident

  • CYP3A4: Cytochrome P450 3A4

  • DES: Drug eluting stent

  • DVT: Deep venous thrombosis

  • GP IIb-IIIa: glycoprotein IIb-IIIa

  • HB: HAS-BLED score

  • ICD: implantable cardioverter defibrillator

  • INR: International normalized ratio

  • IV: Intravenous

  • LMWH: Low molecular weight heparin

  • NOACs: New oral anticoagulants

  • OBR: Intra operative bleeding risk

  • Prim.: primary

  • PCI: Percutaneous coronary intervention

  • PE: Pulmonary embolism

  • P-gp: P-glycoprotein

  • PT: Prothrombin time

  • Prev.: prevention

  • PO: Per Os

  • RA: Regional anaesthesia

  • SC: Subcutaneous

  • Sec.: secondary

  • TER: Thrombo embolic risk

  • TIA: Transient ischemic attack

  • UFH: Unfractionated heparin

  • VKA: Vitamin K antagonist

  • VTE: Venous thromboembolism

Table Graphic Jump Location
Table 1–1A.Overview of antiplatelet agents and anticoagulants with clinically useful information about dosage and perioperative management of patients using this type of drug. The overview was composed from a perspective of medical practice in western europe (Belgium).

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.